Search terms
Results 1 - 10 of 59 - ordered by :
Pages: 1 2 3 4 5 6 ... 6

The best estimate of the incidence of SCD in the general population aged 2075 years is 1 in 1000 individuals that accounts for 18.5% of all deaths.6 In the 140 years age group, the incidence is ...

European Heart Journal, Clinical update, Christopher Semsarian, Jodie Ingles, Arthur A.M. Wilde

Date : 01/06/2015 Item size : 391800 bytes

The deficiency of α-galactosidase A is characteristic and pathognomonic for male patients. [...]diagnostic algorithms and the decision when to initiate enzyme replacement therapy in male patients ...

European Journal of Heart Failure, Weidemann, Frank, Niemann, Markus

Date : 01/06/2010 Item size : 98011 bytes

In this section, we review the current application of genetics in clinical management, focusing on hypertrophic cardiomyopathy as a paradigm; discuss state-of-the-art genetic testing technology; ...

Cardiovascular Research, INVITED SPOTLIGHT REVIEWS, Carolyn Y. Ho, Philippe Charron, Pascale Richard, Francesca Girolami, Karin Y. Van Spaendonck-Zwarts, Yigal Pinto

Date : 01/04/2015 Item size : 534020 bytes

[2] The disease affects all age groups, with marked clinical heterogeneity, ranging from a normal life span without symptoms to poor outcomes such as sudden cardiac death (SCD), advanced heart ...

European Journal of Heart Failure, Wang, Jizheng, Wang, Yilu, Zou, Yubao, Sun, Kai, Wang, Zhimin, Ding, Hu, Yuan, Jinqing, Wei, Wei, Hou, Qing, Wang, Hu, Liu, Xuan, Zhang, Hongju, Ji, Yun, Zhou, ...

Date : 01/09/2014 Item size : 186559 bytes

Myocardial crypts in hypertrophic cardiomyopathy: the new gang in town Since the initial description of hypertrophic cardiomyopathy (HCM) over 50 years ago, the majority of our understanding of this ...

European Heart Journal - Cardiovascular Imaging, EDITORIAL, Ethan J. Rowin, Martin S. Maron

Date : 01/04/2012 Item size : 173266 bytes

Introduction Atherosclerotic coronary artery disease (CAD) and peripheral arterial disease are global public health and socio-economic issues associated with important treatment advances that affect ...

European Heart Journal, CURRENT OPINION, Barry J. Maron, Ankur Kalra

Date : 21/09/2014

Introduction Sudden cardiac death (SCD) is defined as sudden, natural, and unexpected death due to cardiac or unknown causes that occurs, if witnessed, within 1 h of symptom onset and if unwitnessed, ...

Europace, Review, Christin L Hertz, Laura Ferrero-Miliani, Rune Frank-Hansen, Niels Morling, Henning Bundgaard

Date : 01/03/2015

KeywordsLeft ventricular hypertrophyHypertrophic cardiomyopathyTissue Doppler imagingMyocardial stiffness Introduction Sudden death in athletes is a sporting catastrophe.1 Identifying athletes at ...

European Heart Journal - Cardiovascular Imaging, Clinical/Original Paper, Gerard King, Jerome Brendan Foley, Colin Forbes Royse, Konstantin Yastrebov, Matthew Hussey, Gerard Boyle, Kathleen Bennet, ...

Date : 01/12/2006

Genetic testing for pathogenic mutations permits identification of patients with genetic susceptibility for myofilament/sarcomeric HCM before development of LVH. The overall yield of genetic testing ...

European Heart Journal - Cardiovascular Imaging, ORIGINAL ARTICLES, Jeffrey B. Geske, J. Martijn Bos, Bernard J. Gersh, Steve R. Ommen, Benjamin W. Eidem, Michael J. Ackerman

Date : 01/04/2014

[1] (pages 347357) in this issue. 1 Introduction During the last decade, there was a major breakthrough in the molecular genetics of hypertrophic cardiomyopathy (HCM) and a total of nine genes could ...

Cardiovascular Research, Editorial, C Hengstenberg, J Erdmann, P Charron

Date : 01/02/2003